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Objectives. This study sought to characterize leukocyte and
platelet activation and adhesion molecule expression after coro-
nary angioplasty.
Background. Coronary angioplasty can be regarded as a clini-
cal model of postischemic inflammation because this intervention
leads to the release of inflammatory mediators as a result of
plaque rupture and endothelial injury.
Methods. In 13 patients with stable angina (mean [6SEM] age
56.0 6 2.4 years, range 44 to 79), blood samples were drawn from
the aorta and coronary sinus immediately before and immediately
and 15 min after coronary angioplasty. Subsequently, leukocyte
and platelet functions were determined. Eleven control patients
(57.5 6 2.3 years, range 52 to 78) underwent coronary arteriog-
raphy.
Results. Coronary arteriography and angioplasty showed no
difference in number of leukocytes between the coronary sinus and
the aorta. However, 15 min after coronary angioplasty, there was
an increase in neutrophil CD18 and CD11b, monocyte CD14 and
platelet glycoprotein IIb/IIIa expression and a decrease in neu-
trophil L-selectin expression (189 6 25%, 163 6 27%, 158 6 35%,
141 6 22% and 31 6 10%, respectively, p < 0.01). In the control
subjects, no change in adhesion molecule expression occurred.
Superoxide production and aggregation in ex vivo-stimulated
neutrophils collected from the coronary sinus 15 min after
coronary angioplasty was significantly decreased compared with
that after coronary arteriography (54 6 12% vs. 106 6 30% and
58 6 11% vs. 102 6 29%, respectively, p < 0.01). The reduced
responses to phorbol ester stimulation may be explained by
previous in vivo activation of neutrophils during coronary angio-
plasty.
Conclusions. Coronary angioplasty increases neutrophil, mono-
cyte and platelet adhesion molecule expression and induces a
significant decrease in ex vivo-stimulated neutrophil superoxide
generation and aggregation. These findings suggest that coronary
angioplasty triggers cellular activation with an inflammatory
response that could contribute to restenosis.
(J Am Coll Cardiol 1997;29:1276–83)
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Although percutaneous transluminal coronary angioplasty
(PTCA) is widely accepted for the treatment of patients with
critical obstructive coronary artery disease, its pathophysio-
logic implications are not fully understood. For instance,
coronary angioplasty can be regarded as a clinical model of
myocardial ischemia/reperfusion because it is characterized by
successive short periods of myocardial ischemia (1–3). There-
fore, postischemic inflammation may be induced. Another
peculiar aspect of this intervention is that it leads to the release
of inflammatory mediators and chemoattractant factors be-
cause of plaque rupture, arterial wall damage and endothelial
injury (4,5). The recruitment of activated leukocytes, such as
neutrophils and monocytes, and activated platelets to the inflam-
matory site is related to the regulation of adhesion molecules
expressed on the cellular surface. Optimal neutrophil–
endothelial cell interactions involve at least two classes of
adhesion molecules that are expressed on the surface of
neutrophils. These include L-selectin, which is constitutively
expressed on nonactivated leukocytes, and the beta2-integrins,
which are upregulated when neutrophils are stimulated.
L-selectin appears to be responsible for the initial attachment
and rolling of stimulated neutrophils on the endothelium. Firm
adhesion, neutrophil aggregation and transendothelial migra-
tion are mediated by beta2-integrins. These consist of a family
of heterodimers, each of which has a common beta-subunit,
designated CD18, and one of three known alpha-subunits,
designated CD11a (LFA-1), CD11b (Mac-1) and CD11c
(p150,95) (6–8). In monocytes, besides the CD11/CD18 com-
plex, the specific adhesion molecule CD14 is also expressed
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(9). In contrast, adherent platelets contain the integrin glyco-
protein (GP) IIb/IIIa receptor on the surface, the final com-
mon pathway of platelet aggregation (10).
In addition, activated leukocytes release a variety of medi-
ators, for example superoxide radicals, that are potentially
deleterious to the heart and are capable of inducing platelet
activation and aggregation, vasoconstriction and direct inflam-
matory tissue damage. Neutrophils may thus exert direct
cytotoxic effects on coronary vascular and myocardial cells
(11,12).
However, it is still not known whether coronary angioplasty
results in leukocyte and platelet activation and adhesion
molecule expression, which could contribute to restenosis.
Therefore, this study sought to characterize cellular activation
and the surface expression of adhesion molecules of coronary
circulating leukocytes and platelets after coronary angioplasty.
Methods
Study patients. Thirteen patients with stable coronary ar-
tery disease underwent elective coronary angioplasty; their
clinical profile is shown in Table 1. All patients had a history of
effort angina pectoris, with no evidence of a previous myocar-
dial infarction, and all had viable myocardium at risk as
defined by the development of typical chest pain with ST
segment depression $1 mm during an exercise stress test or
reversible perfusion defect on exercise thallium-201 or MIBI
scintigraphy. Approval was obtained from our institutional
review board, and written consent from each patient.
To ensure that neither the technical maneuvers involved in
coronary angioplasty (e.g., vessel puncture and catheter ma-
nipulation) nor the contrast medium used resulted in changes
in cell function, 11 control patients underwent routine coro-
nary arteriography, without coronary angioplasty. For this
purpose, seven men and four women years were studied (mean
[6SEM] age 57.5 6 2.3 years); their clinical profile is shown in
Table 2.
Study protocol. All medications, including aspirin, heparin,
nitrates, calcium channel blocking agents and beta-adrenergic
blocking drugs, were not discontinued for the study; however,
fasting of at least 12 h was required before the procedure.
After premedication with prophylactic antibiotics and local
anesthesia, a 7F catheter was advanced either from the bra-
chial or the femoral vein to the coronary sinus. A sheath was
placed into either the brachial or the femoral artery for
insertion of coronary angiographic and angioplastic catheters.
Before intracoronary manipulations, an intravenous bolus of
15,000 IU of heparin was administered. Blood samples were
obtained at the beginning of the procedure from the coronary
sinus and from the guiding catheter in the aortic root. Coro-
nary angioplasty was performed with balloon dilation catheters
of 2.0- to 3.5-mm diameter; the balloon size chosen for each
patient was based on the diameter of normal segments adja-
cent to the stenosis. The balloon was inflated for 45 to 90 s at
Abbreviations and Acronyms
BSA 5 bovine serum albumin
GP 5 glycoprotein
ICAM-1 5 intercellular adhesion molecule-1
PAF 5 platelet-activating factor
PBS 5 phosphate-buffered saline
PMA 5 phorbol myristate acetate
PTCA 5 percutaneous transluminal coronary angioplasty
Table 1. Clinical Profile of Patients Undergoing Coronary Angioplasty (PTCA group)
Pt No./
Gender
Age
(yr)
Dilated Vessel
(site of stenosis)
Stenosis (%)
Inflation
Time (s)
Balloon
ECG
Changes
Before
PTCA
After
PTCA
Size
(mm)
Pressure
(atm)
1/M 62 LAD (prox) 80 36 320 2.0 4.0 Yes
2/M 58 LCx (prox) 84 39 300 4.0 6.0 Yes
3/M 54 RCA (prox) 82 41 240 3.5 4.0 Yes
4/F 59 LCx (mid) 83 30 240 4.0 10.0 Yes
5/F 52 LAD (mid) 79 44 240 3.5 10.0 Yes
6/M 79 LAD (prox) 90 40 300 3.5 8.0 Yes
7/F 56 LCx (mid) 77 29 240 3.0 10.0 No
8/M 61 LCx (prox) 78 30 300 3.0 8.0 No
9/M 53 LAD (prox) 92 32 300 2.5 10.0 Yes
10/F 44 RCA (distal) 81 34 320 2.5 10.0 Yes
11/M 47 LAD (prox) 75 40 360 3.5 6.0 No
12/M 48 LAD (prox) 90 45 240 3.0 4.0 Yes
13/M 55 LAD (prox) 80 25 300 3.0 8.0 Yes
Mean 56.0 82.4 35.8 284.6 3.2 7.7
6SEM 62.4 61.5 61.7* 611.1 60.2 60.6
*p , 0.001, versus before percutaneous transluminal coronary angioplasty (PTCA). ECG 5 electrocardiographic;
F 5 female; LAD 5 left anterior descending coronary artery; LCx 5 left circumflex coronary artery; M 5 male; prox 5
proximal; Pt 5 patient; RCA 5 right coronary artery.
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a pressure of 4 to 10 atm. Coronary angioplasty was regarded
as successful when the stenotic segment was dilated so that
lumen narrowing was ,50%. Coronary artery diameter was
measured with calipers at the site of maximal obstruction and
at the proximal and distal portions of the obstruction, and
percent lumen narrowing was calculated. Blood samples were
drawn from the aortic root and from the coronary sinus
immediately before as well as immediately and 15 min after the
coronary angioplasty procedure. Subsequently, the blood sam-
ples were processed immediately for cellular adhesion mole-
cule expression and ex vivo-stimulated neutrophil superoxide
generation and aggregation, as indicated later. In addition,
total leukocyte count was determined in each blood sample.
The control patients also received an intravenous injection
of 5,000 IU of heparin and isosorbide dinitrate during the
procedure. Coronary arteriography was performed by the
Sones technique. A 7F catheter was advanced either from the
brachial or the femoral vein to the coronary sinus. Blood
samples were obtained from the aortic root and from the
coronary sinus immediately before as well as immediately and
15 min after the coronary arteriography procedure. All cardio-
vascular medications were discontinued on the day of the
procedure.
Immunofluorescence and flow cytometric assays. Cellular
surface expression of the adhesion molecules CD11b, CD18,
L-selectin (neutrophil), CD14 (monocyte) and GP IIb/IIIa
(platelet) were measured by direct immunofluorescence tech-
niques associated with flow cytometry. According to a previ-
ously described technique (13), adhesion molecule labeling
was performed for 30 min at 4°C, in the dark, using aliquots of
whole (unseparated) blood and saturating concentrations of
respective fluorescent, isotype monoclonal antibodies.
This technique avoided in vitro manipulation capable of
activating cells. The samples were washed with phosphate-
buffered saline (PBS), and the erythrocytes were hemolyzed
and leukocytes and platelets fixed with commercially available
solutions (14). The samples, once centrifuged and dissolved in
PBS, were used for flow cytometric analysis. Samples were run
through a FACStarPLUS flow cytometer (Becton-Dickinson
Immunocytometry Systems) to measure the fluorescent signal.
Gating of the forward and side scatter diagrams was used to
circumscribe the analysis to a homogeneous cell population,
excluding clusters and debris. The laser excitation wavelength
was 488 nm, and the emission light was 578 nm. A frequency
distribution histogram of the fluorescent signal was obtained
from at least 5,000 cells for each sample with a Hewlett-
Packard computer programmed with LYSYS II Profile Ana-
lyzer software.
Negative control for nonspecific flow cytometric back-
ground was performed with carefully isotype-matched, fluores-
cent, nonbinding monoclonal antibodies.
Neutrophils could be distinguished from lymphocytes and
monocytes by the combination of low angle forward and
right-angle scattered laser light, and a cytogram of each cell
population could be generated. The region of interest in the
neutrophil, monocyte or platelet population was identified by
an observer using a computer-aided outlining technique. A
histogram of fluorescence distribution was constructed with
the fluorescence intensity on the abscissa and the number of
cells on the ordinate. The relative mean intensity of fluores-
cence was obtained from the histogram and expressed as an
index of membrane surface expression. Results are expressed
as either arbitrary units or as percentage of the label-matched
coronary sinus/aortic ratio, to account for variability of basal
values among different periods.
Neutrophil preparation and purification. Isolation of neu-
trophils was executed by Ficoll-Hypaque centrifugation, dex-
tran sedimentation of red cells and removal of remaining red
cells by hypotonic lysis (15). This procedure routinely pro-
duced a neutrophil preparation .98% purity and viability.
Determination of neutrophil superoxide production and aggre-
gation was carried out after ex vivo 30 min stimulation with
phorbol myristate acetate (PMA) (final concentration 100
ng/ml).
Determination of neutrophil superoxide production. Rates
of superoxide production were determined by measuring the
reduction of cytochrome c (reduced–oxidized 21.100 mol/liter
per cm) in the presence of 30 mg/ml of superoxide dismutase.
Rates were measured by continuously monitoring A550 with 50
mmol/liter cytochrome c and 106 cells/ml, or the total amount
of superoxide produced during the course of the reaction was
determined from the overall DA550 measured with 150 mmol/
liter cytochrome c and 0.25 3 106 or 0.5 3 106 cells/ml
(Beckman DU-70 Spectrophotometer) (16).
Measurement of neutrophil aggregation. Neutrophil sus-
pensions (20,000 cells/mm3) were suspended in PBS containing
0.1% bovine serum albumin (BSA), 1 mmol/liter calcium
chloride and 0.7 mmol/liter magnesium chloride. Once stimu-
lation was performed with phorbol ester, aggregation was
initiated in a Chrono-Log 440 Dual Channel aggregometer
(Chrono-Log Corp.) with continuous stirring at 1,000 rpm. The
aggregation measures were done by the turbidometric method
Table 2. Clinical Profile of Patients Undergoing Coronary
Arteriography (control group)
Pt No./Gender Age (yr)
Angiographic Findings
1/M 57 Normal
2/M 58 Normal
3/F 50 1-vessel CAD
4/F 59 1-vessel CAD
5/F 52 1-vessel CAD
6/M 78 Mild aortic stenosis
7/F 53 2-vessel CAD
8/M 57 2-vessel CAD
9/M 61 1-vessel CAD
10/M 53 1-vessel CAD
11/M 54 1-vessel CAD
Mean 57.5
6SEM 62.3
CAD 5 coronary artery disease; other abbreviations as in Table 1.
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described by Born and Cross (17). Changes in optical density
were recorded on a Chrono-Log recorder model 707. Results
are expressed in amplitude (cm/min).
Chemicals and reagents. The chemicals and reagents used
in this study were purchased from the sources indicated:
whole-blood lysing reagent kit (Coulter Corp.); monoclonal
antibodies anti-CD11b, anti-CD18, anti-CD14, anti-GP IIb/
IIIa, immunoglobulin G R-phycoerythrin-conjugated second-
ary antibody and negative control nonbinding monoclonal
antibodies (Dako Corp.); monoclonal antibody anti–L-selectin
(Becton-Dickinson Immunocytometry Systems); and, PMA,
Ficoll, Histopaque 1083, cytochrome c, dextran, BSA, calcium
chloride and magnesium chloride (Sigma Chemical Co.).
Statistical analysis. Results are presented as mean value 6
SEM. The variables from each group (control and PTCA
groups) were analyzed separately by the Student t test for
independent samples. Statistical analysis of the time-course
data was performed by two-factor analysis of variance for
repeated measures. When analysis of variance revealed a
statistical significance, the Newman-Keuls test for matched
samples was used. A p value ,0.05 was conventionally as-
sumed to indicate statistical significance.
Results
Coronary angioplasty and control groups. The procedure
was successful in all patients, and no significant complications
occurred. The degree of coronary stenosis was significantly
reduced, from 82.4 6 1.5% to 35.8 6 1.7% (p , 0.001).
Balloon inflation time was 284.6 6 11.1 s (range 240 to 360).
During balloon inflation, 10 patients had ST segment transi-
tory changes, 5 of whom complained of chest pain. However,
no serious complications leading to progression or recurrence
of myocardial infarction occurred. The average amount of
contrast medium used during coronary angioplasty procedure
was 320 ml.
There were no substantial differences between the patients
in the coronary angioplasty group and the control subjects in
their baseline clinical characteristics (Tables 1 and 2). The
control group included 11 patients with coronary artery dis-
ease: 2 had two-vessel disease; 6 had one-vessel disease; 2 had
angiographically normal coronary arteries; and 1 had mild
aortic stenosis associated with mild coronary artery stenosis
,50%. The average amount of contrast medium used during
coronary arteriography was 180 ml, which was not significantly
different from that used during the coronary angioplasty.
Leukocyte count. No differences were observed in total
leukocyte count between the aortic root and the coronary sinus
in patients undergoing either coronary arteriography or angio-
plasty. Control patients had a leukocyte count of 5.4 3 106
cells/ml before, 6.3 3 106 cells/ml immediately after and 5.7 3
106 cells/ml 15 min after coronary arteriography. Patients
undergoing coronary angioplasty had leukocyte counts of 5.3 3
106, 5.9 3 106 and 5.9 3 106 cells/ml, respectively.
Surface expression of leukocyte adhesion molecules. Fig-
ures 1 and 2 show percent changes in mean fluorescence
intensity of CD18, CD11b, L-selectin, CD14 and GP IIb/IIIa in
patients who underwent coronary arteriography or coronary
angioplasty. In the 11 control subjects who underwent routine
coronary arteriography, no change in mean fluorescence inten-
sity was observed among cells collected from the coronary
sinus compared with those from the aortic root. Before coro-
nary arteriography, control patients had mean fluorescence
intensities of aortic and coronary sinus neutrophils for CD18 of
147.9 6 8.7 and 149.2 6 8.2; for CD11b of 70.0 6 5.3 and
70.8 6 5.4; and for L-selectin of 56.2 6 2.6 and 55.2 6 3.0,
respectively. Aortic and coronary sinus monocytes and plate-
lets demonstrated mean fluorescence intensities before coro-
nary arteriography for CD14 of 73.2 6 6.3 and 72.4 6 6.4 and
for GP IIb/IIIa of 94.2 6 5.3 and 93.8 6 6.4, respectively.
In contrast, in the 13 patients undergoing routine coronary
angioplasty, surface expression of the adhesion molecules of
Figure 1. Changes in the fluorescence intensity
of CD18, CD11b and L-selectin in patients who
underwent coronary arteriography and coro-
nary angioplasty. The y-axis shows the changes
between the aorta (Ao) and coronary sinus
(CS) variables. In the control subjects, no
change in fluorescence intensity was observed
among cells collected from the coronary sinus
compared with those from the aortic root. In
the coronary angioplasty group, adhesion mol-
ecule expression of neutrophils collected from
the coronary sinus increased significantly after
15 min of coronary angioplasty (gray bars) for
CD18 and CD11b and decreased immediately
after coronary angioplasty (open bars) for
L-selectin. It is understood that during neutro-
phil activation, L-selectin is rapidly shed before
the upregulation of CD18 and CD11b. Solid
bars 5 immediately before procedure. *p ,
0.01, coronary sinus versus aorta. †p , 0.01,
versus immediately after coronary angioplasty.
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leukocytes and platelets from the coronary sinus was markedly
changed 15 min after coronary angioplasty compared with that
from the aorta. Patients with coronary angioplasty had adhe-
sion molecule surface expression in aortic and coronary sinus
cells preceding the procedure similar to that observed in
control patients. Aortic and coronary sinus mean fluorescence
intensities were 90.5 6 12.8 and 92.3 6 10.9 for neutrophil
CD18, 110.7 6 16.8 and 116.2 6 21.5 for CD11b, and 76.8 6
27.7 and 72.2 6 15.5, for L-selectin, respectively. Aortic and
coronary sinus monocytes and platelets demonstrated mean
fluorescence intensities before coronary angioplasty of 70.8 6
12.5 and 72.2 6 13.5 for CD14 and 100.9 6 15.6 and 95.9 6
20.0 for GP IIb/IIIa. After coronary angioplasty, adhesion
molecule expression of cells from the coronary sinus was
significantly higher than that after coronary arteriography. No
correlation with the amount of contrast medium or balloon
catheter size used during coronary angioplasty was detected
with the adhesion molecule expression of leukocytes and
platelets.
Figure 3 shows typical flow cytometric histograms observed
from those experiments measuring CD18, CD11b and
L-selectin expression of neutrophils collected from the coro-
nary sinus before and 15 min after coronary angioplasty of a
90% stenosis of the left anterior descending coronary artery.
Figure 4 shows representative histograms of CD14 and GP
IIb/IIIa expression from the coronary sinus of the same
patient.
Measurement of neutrophil superoxide production. Figure
5 (left panel) shows changes in ex vivo phorbol ester–
stimulated neutrophils of control subjects and patients who
underwent coronary angioplasty. Superoxide production from
neutrophils collected from the coronary sinus did not change
compared with cells collected from the aortic root immediately
and 15 min after coronary arteriography (from 4.7 6 0.2 to
4.7 6 0.3 and from 4.6 6 0.3 to 4.6 6 0.3 nmolzO2
2/106 cells,
respectively, p 5 NS), whereas superoxide production after
coronary angioplasty significantly decreased (from 4.2 6 2.2
nmolzO2
2/106 cells to 3.1 6 1.9 and 2.3 6 1.9 nmolzO2
2/106
cells immediately and 15 min after angioplasty, respectively,
p , 0.01). Coronary sinus neutrophil superoxide production
Figure 2. Changes in the fluorescence intensity
of CD14 and GP IIb/IIIa in patients who un-
derwent coronary arteriography and coronary
angioplasty. Monocytes and platelets collected
from the coronary sinus (CS) 15 min after
coronary angioplasty demonstrated an upregu-
lation of CD14 and GP IIb/IIIa. These data
suggest that after coronary angioplasty, leuko-
cytes and platelets became activated as they
pass through the heart. Solid bars 5 immedi-
ately before procedure; open bars 5 immedi-
ately after procedure; gray bars 5 15 min after
procedure. *p , 0.01, coronary sinus versus
aorta (Ao).
Figure 3. Histograms from a representative experiment in which
neutrophils collected from the coronary sinus 15 min after coronary
angioplasty (solid graphs) were compared with neutrophils collected
before coronary angioplasty, also from the coronary sinus (dashed-line
graphs). The left panel shows a shift to the right of the fluorescence
intensity of CD18 after coronary angioplasty, representing an upregu-
lation of CD18. A similar effect occurs with CD11b, as seen in the
middle panel. In contrast, L-selectin (right panel) has a downregula-
tion after coronary angioplasty, indicating L-selectin shedding.
Figure 4. Histograms from the same representative experiment as that
in Figure 3, where monocytes and platelets collected from the coronary
sinus 15 min after coronary angioplasty (solid graphs) are compared
with cells collected before coronary angioplasty, also from the coro-
nary sinus (dashed-line graphs). For both CD14, the monocyte
adhesion molecule, and GP IIb/IIIa, the platelet adhesion molecule, a
shift to the right of the fluorescence intensities occurs after coronary
angioplasty, representing an upregulation of CD14 and GP IIb/IIIa.
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after coronary angioplasty was significantly lower than that
after coronary arteriography (coronary angioplasty, p , 0.01).
Neutrophil aggregation. Figure 5 (right panel) shows
changes in aggregation curves obtained from neutrophils col-
lected from the aortic root and the coronary sinus in the
control subjects and in patients who underwent coronary
angioplasty. Neutrophil aggregation in the coronary sinus did
not change compared with that in the aorta immediately and
15 min after coronary arteriography (from 4.7 6 0.3 to 4.8 6
0.3 and from 4.8 6 0.2 to 4.9 6 0.2 cm/min, respectively, p 5
NS), whereas neutrophil aggregation in the coronary sinus
decreased significantly after coronary angioplasty (from 4.9 6
2.9 to 3.2 6 1.8 and 2.8 6 1.9 cm/min immediately and 15 min
after angioplasty, respectively, p , 0.01).
There was no correlation between the changes in neutrophil
superoxide production and aggregation and inflation time,
amount of contrast medium or balloon catheter size used
during coronary angioplasty.
Discussion
Although coronary angioplasty is a commonly used treat-
ment for obstructive coronary artery disease, little is known
regarding leukocyte and platelet function during this interven-
tion. The present study demonstrates that an acute inflamma-
tory response is provoked by coronary angioplasty. We ob-
served that this intervention induced a significant alteration in
membrane surface expression of the adhesion molecules
CD18, CD11b, L-selectin (neutrophil), CD14 (monocyte) and
GP IIb/IIIa (platelet) and induced a significant decrease in the
generation of superoxide in ex vivo phorbol ester–stimulated
neutrophils as well as neutrophil aggregation. No such changes
in leukocyte and platelet functions were found in the control
subjects, who underwent routine coronary arteriography.
Leukocyte adhesion molecules. Our study describes se-
quential changes in the fluorescence intensity of L-selectin,
CD18 and CD11b induced by coronary angioplasty. L-selectin
adhesion molecule expression of neutrophils collected from
the coronary sinus decreased immediately after coronary an-
gioplasty, preceding the marked increase of CD18 and CD11b
expression. During the neutrophil adhesion process, a transi-
tion from L-selectin–mediated adhesion to CD18-mediated
adhesion must take place—L-selectin rapidly sheds from the
neutrophil surface before the upregulation of Mac-1 (18–21).
In agreement with our study, Haught et al. (20) recently
identified abnormalities in circulating intercellular adhesion
molecule-1 (ICAM-1) and soluble L-selectin (shed form of
L-selectin) levels in patients with coronary artery disease
regardless of white blood cell counts, clinical status or severity
of disease (20).
From our study, it is uncertain whether the changes in
leukocyte and platelet adhesion molecules could persist for
.15 min in patients undergoing coronary angioplasty. How-
ever, other studies have provided evidence for the presence of
chronic inflammation in coronary artery disease, suggesting
that inflammation is not merely a manifestation of acute
myocardial ischemia (20). In addition, in an experimental
study, local inflammatory activation of endothelial cells and
leukocytes lasts up to 30 days after balloon injury in the rabbit
aorta (22).
Leukocyte and platelet activation after coronary angio-
plasty. Two explanations can be proposed as to why coronary
angioplasty activated coronary circulating leukocytes and
platelets in our patients:
1. Coronary angioplasty can be viewed as a clinical model of
myocardial ischemia/reperfusion because its procedures are
characterized by successive short periods of myocardial isch-
emia (1–3). Reperfusion of ischemic myocardium initiates a
deleterious cascade of events leading to further myocardial
injury (23,24). Leukocytes, mainly neutrophils, are important
mediators of this phenomenon. An essential initiating step in
the process of neutrophil-mediated injury within the heart
involves the activation and adhesion of circulating neutrophils
to the coronary endothelium (25).
2. Coronary angioplasty causes plaque rupture, arterial wall
damage and endothelial injury, which in turn provokes the
release of inflammatory and chemoattractant factors (4,5).
These factors provide the signal for leukocytes to enter the
inflamed tissue (6,19). In addition, platelet adhesion and
aggregation may also take place as a result of arterial wall
damage as part of the inflammatory response (26). This
potential interaction between platelets, leukocytes and endo-
thelial cells is a fertile ground for the upregulation of CD11b/
CD18. Perhaps most directly, thrombin stimulates the enzy-
Figure 5. Changes in ex vivo phorbol ester–
stimulated neutrophils from control subjects and
patients who underwent coronary angioplasty
(PTCA). Left, Superoxide production from neu-
trophils collected from the coronary sinus (CS)
did not change compared with cells collected
from the aortic root (Ao) after coronary arteriog-
raphy, whereas superoxide production after cor-
onary angioplasty significantly decreased. Right,
Neutrophil aggregation decreased significantly
after coronary angioplasty. Symbols as in Figure
2. *p , 0.01, coronary sinus versus aorta. †p ,
0.01, versus immediately after coronary angio-
plasty.
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matic pathway leading to the formation of platelet-activating
factor (PAF), which is a potent chemotactic agent that in
addition, to platelet activation, increases surface expression
and activation of CD11b/CD18 and promotes neutrophil ad-
hesion to endothelial cells as well as homotypic aggregation of
neutrophils (10,27–29).
Leukocyte adhesion. Even though changes in leukocyte
adhesion molecule expression occurred after coronary angio-
plasty, no differences were observed in the leukocyte count
between the aortic root and the coronary sinus. Although some
infiltration of leukocytes may occur, one presupposes that most
of the activated leukocytes are released to move downstream.
It is likely that leukocytes escape from adhesion complexes
induced in this turbulent circulation because of hemodynamic
variability, shifting shear stress conditions, alterations in levels
of generated thrombin and the intrinsic instability of the
selectin adhesion molecules (30,31). Thus, in a phasic condi-
tion such as after coronary angioplasty, it is easy to imagine
that the high pressure flow (shear stress) system could ulti-
mately project the leukocytes downstream out of the postob-
structive chamber.
Neutrophil superoxide release and hyperaggregability after
coronary angioplasty. The reduced responses of neutrophil
superoxide generation and aggregation to phorbol ester stim-
ulation observed after coronary angioplasty may be explained
by previous in vivo activation (priming) of neutrophils. Phorbol
ester is considered to induce maximal neutrophil activation
(32). Accordingly, Dinerman et al. (33) have demonstrated in
patients with acute myocardial ischemia that ongoing in vivo
neutrophil activation results in diminished in vitro activity.
They suggest that neutrophil stimulation, specifically enhanced
release of elastase, after interventions that attempt to restore
blood flow to jeopardized myocardium may contribute to the
progression and severity of ischemic heart disease.
Our study suggests a pathogenic link between the surface
expression of leukocyte adhesion molecules and the generation
of superoxide in patients who underwent coronary angioplasty.
Superoxide radicals are important mediators of leukocyte–
endothelial cell interactions observed after reperfusion of the
ischemic heart (34). In addition to triggering the upregulation
of CD18, there are several other mechanisms by which super-
oxide radicals might trigger reperfusion-induced leukocyte
adherence. Superoxide radicals react with the endothelial cell
to produce and release humoral mediators, including leukotri-
ene B4 and PAF, which in turn activate and promote the
adherence of leukocytes (21). Superoxide may also induce the
expression of endothelial adhesion molecules, such as
P-selectin and ICAM-1 (35,36). Another possible mechanism
by which superoxide might further promote neutrophil adhe-
sion is by inactivation of nitric oxide, an endothelial-derived
vasodilator that interferes with neutrophil adherence to micro-
vascular endothelium (37,38). Furthermore, reactive oxygen
metabolites secreted by activated neutrophils, such as those
after coronary angioplasty, can amplify the response to injury
and may potentiate platelet activation and vasoconstriction
(39).
The increased aggregation present in the neutrophils of our
patients who underwent coronary angioplasty is consistent with
previous reports (40). Homotypic aggregation may occur
through a CD11/CD18-dependent mechanism and result in
leucostatic plugs, leading to microvascular occlusion (30,34,41).
However, because the coronary circulation has an unusual
microcirculation, activated leukocytes as well as activated
platelets may be trapped not in the coronary circulation but in
either the pulmonary circulation or the spleen and thus
disappear from the systemic circulation (30).
Clinical implications. Regardless of the mechanism trig-
gering neutrophil and monocyte activation after coronary
angioplasty, the generation of oxygen free radicals along with
the release of other inflammatory mediators may aggravate the
endothelial damage induced by coronary angioplasty and fur-
ther stimulate platelets.
Thus, leukocyte and platelet activation after coronary an-
gioplasty in humans may trigger the pathophysiologic chain
reaction that eventually results in coronary restenosis. How-
ever, further studies are required to evaluate the implications
of these findings and to define fully the mechanisms by which
the complex interaction of leukocyte–endothelial cell–platelet
contributes to restenosis.
We gratefully thank Izabel K. Tutiya, BSc for technical assistance in flow
cytometry.
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